Product correctly added to cart.

discount label
PF-03049423
View 3D

Biosynth logo

PF-03049423

CAS: 402955-58-2

Ref. 3D-CRA95558

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 25 Nov 2024

Product Information

Name:
PF-03049423
Description:

PF-03049423 is a drug that belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors. It is a potent and selective inhibitor of PDE5 with neuroprotective properties. In addition, PF-03049423 has been shown to be effective in the treatment of chronic kidney disease, with potential for less side effects than other drugs. This drug has also been shown to have physiological effects on tissues such as lung, heart, and liver. A multicenter study demonstrated that PF-03049423 can significantly reduce infarct size and improve neurological function following an acute ischemic event such as a stroke. The results of this study were confirmed by animal studies showing that PF-03049423 can reduce tissue damage from ischaemic injury.
PF-03049423 has also been evaluated in clinical trials for the treatment of erectile dysfunction, with promising results so far.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
505 g/mol
Formula:
C24H33ClN6O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-CRA95558 PF-03049423

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".